FDA issues 'transformative' authorization of Pfizer's COVID vaccine for children ages 5 to 11


The Food and Drug Administration moved to give Pfizer's COVID-19 vaccine emergency use authorization for American children ages 5 to 11. The Friday decision, which was expected, was heralded as a "watershed moment," "transformative news" for parents, and a "hotly anticipated" milestone in the effort to end the pandemic.
The Pfizer-BioNTech vaccine got the green light from the FDA, and now just needs to be recommended by the Centers for Disease Control and Prevention. That recommendation may come shortly after a Nov. 2 CDC committee meeting.
Roughly 28 million American children will be allowed to be vaccinated once the authorization is finalized, though The Washington Post notes that officials are expecting some level of hesitation from parents who may prefer to wait for full FDA approval or agree with some advisory panelists who argued not all children need the vaccine, because the risk of COVID-19 complications is lower in most kids. However, polling has showed most parents will welcome the vaccine for their children. Stat News notes the Pfizer vaccine was found to be almost 91 percent effective in preventing COVID-19 in kids ages 5 to 11, and didn't cause any serious complications.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy," said acting FDA Commissioner Janet Woodcock. "Our comprehensive and rigorous evaluation of the data pertaining to the vaccine's safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards."
If and when CDC Director Rochelle Walensky signs off on emergency authorization for the age group next week, providers will be able to begin administering shots same-day.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
Bluetoothing: the phenomenon driving HIV spike in Fiji
Under the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Marisa Silver’s 6 favorite books that capture a lifetime
Feature The author recommends works by John Williams, Ian McEwan, and more
-
Book reviews: ‘We the People: A History of the U.S. Constitution’ and ‘Will There Ever Be Another You’
Feature The many attempts to amend the U.S. Constitution and Patricia Lockwood’s struggle with long Covid
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?
The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy